MR
Maravai LifeSciences Holdings, Inc.
MRVI · NASDAQ
$7.17 +2.65% (+$0.18)
1M -14.95%
Market Cap $1.04B
P/E Ratio -
Div. Yield -
ROE 35.42%
Bulios Fair Price
$6.34
11.6% downside
Trenutna cena
$7.17
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MRVI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
35 /100
Fair P/S 4.98x
P/B 5.08x
P/E N/A
Growth
0 /100
Declining Rev. growth 40.53%
Book val. growth 26.97%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 34.61%
Net margin 37.07%
Op. margin 46.02%
Quality
39 /100
Average ROIC 16.91%
ROE 35.42%
ROA 12.82%
Debt
50 /100
Moderate Debt/Equity 0.86x
Current ratio 4.05x
Int. coverage -4.70x
Stability
35 /100
Moderate Beta 0.61x
Rev. volatility 29.12%
EPS volatility 89.16%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MRVI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bernd Brust
Employees
415
Headquarters
San Diego
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report